Early-stage
IDG Capital et al. back $67m series-C for Hifibio
Latest round follows $38m series-B led by Sequoia China and Lyfe Capital in Q2 2018
Axeleo leads €1.2m seed round for DataHawk
Company plans to use the funding to boost its growth, targeting 1,000 paying subscribers by 2020
Kernel Capital leads £2m round for Silform
Funding will be used to establish a pilot plant in Northern Ireland and scale the R&D team
Parkwalk, Oxford Sciences Innovation back MoA Technology
VC firms provide the crop protection discovery company with a £6.3m series-A
LSP et al. in €67m series-A for Alizé Pharma 3
LSP leads the round for the biotech business, investing alongside previous and new backers
BtoV, Wellington and Seroba co-lead $48m series-C for Quanta
Existing investors BtoV, Wellington and Seroba all invested in the company's series-A in 2009
Sunstone backs Forendo Pharma
Fresh capital will be used to advance its endometriosis programme into the next phase
VCs invest €7m in CryoTherapeutics
Existing investors Creathor Ventures and Peppermint Venture Partners participate in the round
Caixa Capital leads €55.2m series-D for Sanifit
New backers Columbus Venture Partners and Alta Life Sciences also take part in the investment
Benchmark leads $21.5m series-A for travel startup Duffel
Previous backers Blossom Capital and Index Ventures also take part in the funding round
ADC Therapeutics gathers $76m in series-E extension
Headquartered in Lausanne, ADC Therapeutics has raised $531m since its inception in 2012
IBB and E.On invest in Nuventura
Consortium of IBB, E.On, Apex Energy Teterow and business angels have invested €3-7m in Nuventura
VCs invest £14m in Storm Therapeutics
Storm Therapeutics has now raised more than £30m in capital from its new and existing investors
Syncona leads £35m series-A for Quell
UCL Technology Fund also took part in the round for the newly launched cell therapy company
BIVF, UCB Ventures lead £1.4m round for Rinri
Representatives from BIVF, UCB Ventures and BioCity have joined the company's board of directors
MIG in $25m series-C for Cynora
Investors include family office Wecken & Cie, SBI, Dboled and SRF Partners Group
BioGeneration, Wellington lead €30m series-A for Confo
Fund+ and Perceptive Advisors, Capricorn, Qbic, PMV, Mints, V-Bio Ventures and VIB joined the round
Panakès Partners in CHF 9.5m round for SamanTree
Panakès Partners is using equity from its Fund I, which invests €5-6m in European startups
Consortium invests CHF 12.5m in Alentis
BioMedPartners, BB Pureos Bioventures, BPI France, Schroder Adveq and HTGF participate in the deal
BPI leads €13m series-A for NH TherAguix
Omnes Capital, BPI France and investment management firm Arbevel are new investors
Consortium raises €21m for AgomAb
Representatives from V-Bio, Advent Biotechnology, BIVF, Omnes and Pontifax have joined the board
VCs in $12m series-A for Polystream
London Venture Partners invested in seed rounds for the company in 2015 and 2016
Sofinnova, NEA in CHF 22.5m funding round for Polyneuron
Polyneuron develops biodegradable glycopolymers for the treatment of autoimmune diseases
Subversive Capital in $43m series-B for Atai Life Sciences
Other investors in the round include Aperion Investment Group and Bail Capital
